Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Journal of Computational Chemistry
|
September 15, 2010
Mechanism of the decrease in catalytic activity of human cytochrome P450 2C9 polymorphic variants investigated by computational analysis
Eri Sano, Weihua Li, Hitomi Yuki, et al.
The Journal of Physical Chemistry Letters
|
April 6, 2023
Quantum Chemical Interaction Analysis between SARS-CoV-2 Main Protease and Ensitrelvir Compared with Its Initial Screening Hit
Chiduru Watanabe, Shigenori Tanaka, Yoshio Okiyama, et al.
Journal of Chemical Information and Modeling
|
November 8, 2017
Theoretical Analysis of Activity Cliffs among Benzofuranone-Class Pim1 Inhibitors Using the Fragment Molecular Orbital Method with Molecular Mechanics Poisson-Boltzmann Surface Area (FMO+MM-PBSA) Approach
Chiduru Watanabe, Hirofumi Watanabe, Kaori Fukuzawa, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 18, 2017
Identification of pyrrolo[2,3-d]pyrimidines as potent HCK and FLT3-ITD dual inhibitors
Yasuko Koda, Ko Kikuzato, Junko Mikuni, et al.
Bioorganic & Medicinal Chemistry
|
July 1, 2017
Activity cliff for 7-substituted pyrrolo-pyrimidine inhibitors of HCK explained in terms of predicted basicity of the amine nitrogen
Hitomi Yuki, Ko Kikuzato, Yasuko Koda, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications
|
August 8, 2012
Flexibility of the P-loop of Pim-1 kinase: observation of a novel conformation induced by interaction with an inhibitor
Lorien J Parker, Hisami Watanabe, Keiko Tsuganezawa, et al.
Bioorganic & Medicinal Chemistry
|
May 20, 2022
New antimalarials identified by a cell-based phenotypic approach: Structure-activity relationships of 2,3,4,9-tetrahydro-1H-β-carboline derivatives possessing a 2-((coumarin-5-yl)oxy)alkanoyl moiety
Nobuo Cho, Ko Kikuzato, Yushi Futamura, et al.
Plos One
|
February 4, 2021
The ubiquinone synthesis pathway is a promising drug target for Chagas disease
Takeshi Nara, Yukari Nakagawa, Keiko Tsuganezawa, et al.
Journal of Molecular Biology
|
February 7, 2012
A novel Pim-1 kinase inhibitor targeting residues that bind the substrate peptide
Keiko Tsuganezawa, Hisami Watanabe, Lorien Parker, et al.
Bioorganic & Medicinal Chemistry
|
May 22, 2012
Identification of novel drug-resistant EGFR mutant inhibitors by in silico screening using comprehensive assessments of protein structures
Tomohiro Sato, Hisami Watanabe, Keiko Tsuganezawa, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Journal of Computational Chemistry
|
September 15, 2010
Mechanism of the decrease in catalytic activity of human cytochrome P450 2C9 polymorphic variants investigated by computational analysis
Eri Sano, Weihua Li, Hitomi Yuki, et al.
The Journal of Physical Chemistry Letters
|
April 6, 2023
Quantum Chemical Interaction Analysis between SARS-CoV-2 Main Protease and Ensitrelvir Compared with Its Initial Screening Hit
Chiduru Watanabe, Shigenori Tanaka, Yoshio Okiyama, et al.
Journal of Chemical Information and Modeling
|
November 8, 2017
Theoretical Analysis of Activity Cliffs among Benzofuranone-Class Pim1 Inhibitors Using the Fragment Molecular Orbital Method with Molecular Mechanics Poisson-Boltzmann Surface Area (FMO+MM-PBSA) Approach
Chiduru Watanabe, Hirofumi Watanabe, Kaori Fukuzawa, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 18, 2017
Identification of pyrrolo[2,3-d]pyrimidines as potent HCK and FLT3-ITD dual inhibitors
Yasuko Koda, Ko Kikuzato, Junko Mikuni, et al.
Bioorganic & Medicinal Chemistry
|
July 1, 2017
Activity cliff for 7-substituted pyrrolo-pyrimidine inhibitors of HCK explained in terms of predicted basicity of the amine nitrogen
Hitomi Yuki, Ko Kikuzato, Yasuko Koda, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications
|
August 8, 2012
Flexibility of the P-loop of Pim-1 kinase: observation of a novel conformation induced by interaction with an inhibitor
Lorien J Parker, Hisami Watanabe, Keiko Tsuganezawa, et al.
Bioorganic & Medicinal Chemistry
|
May 20, 2022
New antimalarials identified by a cell-based phenotypic approach: Structure-activity relationships of 2,3,4,9-tetrahydro-1H-β-carboline derivatives possessing a 2-((coumarin-5-yl)oxy)alkanoyl moiety
Nobuo Cho, Ko Kikuzato, Yushi Futamura, et al.
Plos One
|
February 4, 2021
The ubiquinone synthesis pathway is a promising drug target for Chagas disease
Takeshi Nara, Yukari Nakagawa, Keiko Tsuganezawa, et al.
Journal of Molecular Biology
|
February 7, 2012
A novel Pim-1 kinase inhibitor targeting residues that bind the substrate peptide
Keiko Tsuganezawa, Hisami Watanabe, Lorien Parker, et al.
Bioorganic & Medicinal Chemistry
|
May 22, 2012
Identification of novel drug-resistant EGFR mutant inhibitors by in silico screening using comprehensive assessments of protein structures
Tomohiro Sato, Hisami Watanabe, Keiko Tsuganezawa, et al.
Page
of 3